SG Americas Securities, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2022$48,000
-50.0%
23,756
-32.9%
0.00%
-100.0%
Q4 2021$96,000
-69.8%
35,409
-50.4%
0.00%0.0%
Q3 2021$318,000
+186.5%
71,350
+274.0%
0.00%0.0%
Q2 2021$111,000
-80.4%
19,079
-76.3%
0.00%
-66.7%
Q1 2021$565,000
+191.2%
80,529
+99.6%
0.00%
+200.0%
Q4 2020$194,000
-77.7%
40,345
-73.0%
0.00%
-83.3%
Q3 2020$870,000
-36.3%
149,176
-26.2%
0.01%
-45.5%
Q2 2020$1,365,000
-64.2%
202,192
-66.3%
0.01%
-69.4%
Q1 2020$3,812,000
+1960.5%
599,414
+1174.6%
0.04%
+1700.0%
Q3 2019$185,000
-86.1%
47,027
-47.5%
0.00%
-77.8%
Q2 2019$1,332,000
-44.8%
89,553
-7.8%
0.01%
-59.1%
Q1 2019$2,411,000
+196.9%
97,148
+114.9%
0.02%
+214.3%
Q4 2018$812,000
+560.2%
45,201
+1571.0%
0.01%
+600.0%
Q2 2018$123,000
-82.0%
2,705
-79.2%
0.00%
-80.0%
Q1 2018$685,000
+55.7%
12,974
+100.4%
0.01%
+25.0%
Q4 2017$440,000
-2.2%
6,475
+18.5%
0.00%0.0%
Q3 2017$450,000
-75.1%
5,465
-71.7%
0.00%
-75.0%
Q2 2017$1,808,000
+492.8%
19,313
+302.9%
0.02%
+433.3%
Q1 2017$305,000
-74.8%
4,793
-82.4%
0.00%
-70.0%
Q4 2016$1,209,000
+837.2%
27,215
+305.0%
0.01%
+900.0%
Q1 2016$129,000
-79.9%
6,719
-3.8%
0.00%
-75.0%
Q3 2015$642,000
+112.6%
6,981
+103.0%
0.00%
+100.0%
Q2 2015$302,000
-55.1%
3,439
-62.0%
0.00%
-50.0%
Q1 2015$672,000
+171.0%
9,059
+104.3%
0.00%
+300.0%
Q4 2014$248,000
+117.5%
4,435
+76.6%
0.00%0.0%
Q3 2014$114,000
-49.1%
2,512
-53.5%
0.00%0.0%
Q2 2014$224,000
+28.0%
5,398
+87.9%
0.00%0.0%
Q3 2013$175,0002,8730.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders